[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL174770A0 - Anti-insulin-like growth factor-i-receptor antibodies - Google Patents

Anti-insulin-like growth factor-i-receptor antibodies

Info

Publication number
IL174770A0
IL174770A0 IL174770A IL17477006A IL174770A0 IL 174770 A0 IL174770 A0 IL 174770A0 IL 174770 A IL174770 A IL 174770A IL 17477006 A IL17477006 A IL 17477006A IL 174770 A0 IL174770 A0 IL 174770A0
Authority
IL
Israel
Prior art keywords
insulin
growth factor
receptor antibodies
antibodies
receptor
Prior art date
Application number
IL174770A
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/729,441 external-priority patent/US8034904B2/en
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of IL174770A0 publication Critical patent/IL174770A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
IL174770A 2003-12-08 2006-04-04 Anti-insulin-like growth factor-i-receptor antibodies IL174770A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/729,441 US8034904B2 (en) 2002-06-14 2003-12-08 Anti-IGF-I receptor antibody
PCT/US2004/038230 WO2005061541A1 (en) 2002-06-14 2004-12-07 Anti-igf-i receptor antibody

Publications (1)

Publication Number Publication Date
IL174770A0 true IL174770A0 (en) 2006-08-20

Family

ID=36616549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL174770A IL174770A0 (en) 2003-12-08 2006-04-04 Anti-insulin-like growth factor-i-receptor antibodies

Country Status (13)

Country Link
EP (1) EP1692176A4 (en)
JP (1) JP2008502589A (en)
KR (1) KR20070001883A (en)
CN (1) CN1886424A (en)
AU (1) AU2004303792A1 (en)
BR (1) BRPI0417406A (en)
CA (1) CA2548065A1 (en)
CR (1) CR8426A (en)
EA (1) EA009807B1 (en)
EC (1) ECSP066595A (en)
IL (1) IL174770A0 (en)
MX (1) MXPA06005540A (en)
NO (1) NO20063155L (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010339770B2 (en) 2009-12-21 2015-02-12 Genentech, Inc. Antibody formulation
KR20130065665A (en) * 2010-05-11 2013-06-19 아베오 파마슈티컬즈, 인크. Anti-fgfr2 antibodies
EP2766478A4 (en) * 2011-10-10 2015-06-17 Los Angeles Childrens Hospital Novel asparaginase and methods for treating diseases associated with asparagine dependence
CN103509117B (en) * 2013-05-06 2016-03-09 江苏匡亚生物医药科技有限公司 Bi-specific antibody of anti-human HER2 and people IGF-IR and its production and use
KR20230170992A (en) * 2017-05-30 2023-12-19 데이진 화-마 가부시키가이샤 Anti-igf-i receptor antibody
CN118615438A (en) * 2023-03-07 2024-09-10 康方药业有限公司 Pharmaceutical combination comprising anti-CTLA 4-anti-PD-1 bispecific antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002532685A (en) * 1998-12-04 2002-10-02 ノバルティス アクチエンゲゼルシャフト Methods and compositions useful for targeting activated vitronectin receptor αVβ3
AP2072A (en) * 2001-01-05 2009-12-10 Pfizer Antibodies to insulin-like growth factor I receptor
US7538195B2 (en) * 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
KR20070086866A (en) * 2003-02-13 2007-08-27 화이자 프로덕츠 인크. Uses of anti-insulin-like growth factor ⅰ receptor antibodies

Also Published As

Publication number Publication date
EP1692176A1 (en) 2006-08-23
CR8426A (en) 2007-12-04
JP2008502589A (en) 2008-01-31
CA2548065A1 (en) 2005-07-07
MXPA06005540A (en) 2006-08-17
ECSP066595A (en) 2006-10-17
CN1886424A (en) 2006-12-27
BRPI0417406A (en) 2007-04-03
EP1692176A4 (en) 2008-11-12
AU2004303792A1 (en) 2005-07-07
NO20063155L (en) 2006-08-11
KR20070001883A (en) 2007-01-04
EA009807B1 (en) 2008-04-28
EA200600931A1 (en) 2006-10-27

Similar Documents

Publication Publication Date Title
IL243914A0 (en) Anti-vegf antibodies
IL169690A0 (en) Uses of anti-insulin-like growth factor i receptor antibodies
EP1616881A4 (en) Anti-mpl antibodies
IL175608A0 (en) Antibodies
IL173557A0 (en) Variable antibodies
IL202681A0 (en) Interleukin-10 antibodies
EP1494693A4 (en) Cripto-specific antibodies
IL174770A0 (en) Anti-insulin-like growth factor-i-receptor antibodies
EP1598368A4 (en) Anti-pci neutralizing antibodies
AU2003221663A1 (en) Hair growth
HU0300097V0 (en) Slotmachine for flower
IL172511A0 (en) Specific human antibodies
EP1646078A4 (en) Epitaxial growth process
GB0322082D0 (en) Growth can
AP2740A (en) Anti-VEGF antibodies
EP1641929A4 (en) Floral transformation
GB0317974D0 (en) Novel antibodies
GB0329711D0 (en) Antibodies
AU2003901902A0 (en) Improved planter point
GB0326734D0 (en) Growth method
GB0319345D0 (en) Variable antibodies
GB0319118D0 (en) Variable antibodies
AU2003906592A0 (en) Ligature carrier
AU2004901747A0 (en) Novel growth factor
AU2003906928A0 (en) Cyclospora Antibodies